Here’s whether Opko Health Inc. (OPK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: 50-day MA is rising (+1.25% over 10 days). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); RSI 17 — oversold; weak 1-year return of -12.9%. Currently 24.0% off its 52-week high. Score: -4/7.
OPK is trading below its 200-day MA ($1.30) — a key warning sign the longer-term trend is under pressure. An RSI of 16.7 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -12.9% compares to +16.5% for SPY (trailed the market by 29.3%). The current 24.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $8,714 today
vs. S&P 500 (SPY) — same period trailed market by 29.3%